Clinical significance of plasma presepsin levels in patients with systemic lupus erythematosus-Reference-Cited by-同舟云学术

Clinical significance of plasma presepsin levels in patients with systemic lupus erythematosus

Published:2017-12-14 Issue:5 Volume:28 Page:865-871
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Tanimura Shun¹,Fujieda Yuichiro¹,Kono Michihiro¹,Shibata Yuhei¹,Hisada Ryo¹,Sugawara Eri¹,Nakamura Hiroyuki¹,Ohmura Kazumasa¹,Shimamura Sanae¹,Mitani Asako²,Shida Haruki¹,Watanabe Toshiyuki³,Kato Masaru¹,Oku Kenji¹,Bohgaki Toshiyuki¹,Amengual Olga¹,Yasuda Shinsuke¹,Shimizu Chikara²,Atsumi Tatsuya¹

Affiliation:

1. Department of Rheumatology, Endocrinology and Nephrology, Graduate School of Medicine and Faculty of Medicine, Hokkaido University, Sapporo, Japan;

2. Division of Laboratory and Transfusion Medicine, Hokkaido University, Sapporo, Japan;

3. Hokkaido Medical Center for Rheumatic Diseases, Sapporo, Japan

Funder

Takeda Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd.

AbbVie Inc.

Daiichi Sankyo Co., Ltd.

Astellas Phrma Inc

AYUMI Pharmaceutical Co.

ASAHI KASEI PHARMA CORPORATION

Eisai Co., Ltd.

Mitsubishi Tanabe Phrama Co.

Bristol-Myers Squibb Co.